Catalyst Capital Advisors LLC Trims Stake in Healthequity Inc (HQY)

Catalyst Capital Advisors LLC trimmed its holdings in Healthequity Inc (NASDAQ:HQY) by 14.8% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 7,917 shares of the company’s stock after selling 1,377 shares during the quarter. Catalyst Capital Advisors LLC’s holdings in Healthequity were worth $594,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. New York State Teachers Retirement System lifted its position in Healthequity by 2.5% in the second quarter. New York State Teachers Retirement System now owns 34,957 shares of the company’s stock worth $2,625,000 after purchasing an additional 841 shares during the period. Mason Street Advisors LLC lifted its position in Healthequity by 7.0% in the first quarter. Mason Street Advisors LLC now owns 14,307 shares of the company’s stock worth $866,000 after purchasing an additional 934 shares during the period. Aperio Group LLC lifted its position in Healthequity by 6.3% in the second quarter. Aperio Group LLC now owns 17,977 shares of the company’s stock worth $1,350,000 after purchasing an additional 1,064 shares during the period. Keeler Thomas Management LLC lifted its position in Healthequity by 13.5% in the first quarter. Keeler Thomas Management LLC now owns 10,100 shares of the company’s stock worth $611,000 after purchasing an additional 1,200 shares during the period. Finally, Envestnet Asset Management Inc. lifted its position in Healthequity by 22.8% in the first quarter. Envestnet Asset Management Inc. now owns 6,677 shares of the company’s stock worth $416,000 after purchasing an additional 1,239 shares during the period. 95.38% of the stock is owned by institutional investors.

Healthequity stock opened at $86.86 on Friday. Healthequity Inc has a 52-week low of $40.21 and a 52-week high of $87.79. The firm has a market cap of $5.12 billion, a price-to-earnings ratio of 160.85, a P/E/G ratio of 3.43 and a beta of 1.37.

Healthequity (NASDAQ:HQY) last released its quarterly earnings data on Monday, June 4th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.22 by $0.09. Healthequity had a return on equity of 13.47% and a net margin of 22.91%. The firm had revenue of $69.90 million during the quarter, compared to analyst estimates of $68.81 million. During the same period in the prior year, the company posted $0.23 earnings per share. The business’s revenue for the quarter was up 26.2% compared to the same quarter last year. equities analysts anticipate that Healthequity Inc will post 0.72 EPS for the current fiscal year.

In other Healthequity news, VP Darcy G. Mott sold 9,500 shares of the stock in a transaction on Monday, May 21st. The stock was sold at an average price of $73.93, for a total transaction of $702,335.00. Following the completion of the transaction, the vice president now directly owns 111,500 shares in the company, valued at $8,243,195. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Gary D. Robinson sold 2,100 shares of the stock in a transaction on Thursday, June 7th. The stock was sold at an average price of $80.49, for a total value of $169,029.00. Following the transaction, the executive vice president now owns 4,990 shares of the company’s stock, valued at $401,645.10. The disclosure for this sale can be found here. Insiders have sold 57,100 shares of company stock valued at $4,457,965 over the last quarter. Corporate insiders own 4.00% of the company’s stock.

HQY has been the subject of several research reports. JPMorgan Chase & Co. initiated coverage on Healthequity in a research report on Tuesday, April 24th. They issued an “overweight” rating and a $69.00 target price for the company. Zacks Investment Research cut Healthequity from a “buy” rating to a “hold” rating in a research report on Saturday, May 12th. ValuEngine raised Healthequity from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, May 22nd. Bank of America initiated coverage on Healthequity in a research report on Wednesday, May 23rd. They issued a “buy” rating and a $83.00 target price for the company. Finally, Cantor Fitzgerald cut Healthequity from an “overweight” rating to a “neutral” rating and set a $65.00 target price for the company. in a research report on Wednesday, May 30th. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $77.73.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Read More: What are the Different Types of Leveraged Buyouts?

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthequity Inc (NASDAQ:HQY).

Institutional Ownership by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply